Evidence map›Paper›PMID 39022283›Full record

ArticleQuantitative imaging in medicine and surgery2024

Nomogram of magnetic resonance imaging (MRI) histogram analysis to predict telomerase reverse transcriptase promoter mutation status in glioblastoma.

Bin Zhang, Qing Zhou, Caiqiang Xue, Xiaoai Ke, Peng Zhang, Tao Han, Liangna Deng, Mengyuan Jing, Junlin Zhou

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bin Zhang *Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-0352-3689
Qing Zhou *Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Caiqiang XueDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Xiaoai KeDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Peng ZhangDepartment of Pathology, Lanzhou University Second Hospital, Lanzhou, China.
Tao HanDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Liangna DengDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Mengyuan JingDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Junlin ZhouDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0001-8109-6347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Telomerase reverse transcriptase promoter (p Methods: The clinical and imaging data of 181 patients with GBM at our hospital between November 2018 and April 2023 were retrospectively assessed. We used the molecular sequencing results to classify the datasets into p Results: Patient age and percentage of unenhanced tumor area showed statistically significant differences between the p Conclusions: T1C histogram parameters can be used to evaluate p

Indexed as

Glioblastoma (GBM)histogram analysismagnetic resonance imaging (MRI)nomogramtelomerase reverse transcriptase promoter (pTERT)

Identifiers

PMID39022283
PMCPMC11250314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.